b102273862413112a5d41305d1544e82

2. ARDS INTERNAL QC CONTROL MARCA: RANDOX

BIOLORE LTDA·I·Colombia INVIMA·Expires February 22, 2034
Device classification
Risk class / Clase de Riesgo
I
Product type (Spanish)
REACTIVOS IN VITRO
Product type (English)
REACTIVOS IN VITRO
Registration information
Analysis ID
b102273862413112a5d41305d1544e82
Expire date
February 22, 2034
Authorized company / Fabricante
Name (Spanish)
BIOLORE LTDA
Name (English)
BIOLORE LTDA
Product use / Uso del Producto
Spanish

LOS CONTROLES RANDOX EVIDENCE MULTISTAT ARDS ESTÁN DISEÑADOS PARA USARSE COMO CONTROL DE CALIDAD ANALIZADO EN EL MONITOREO DE RUTINA DE_x000D_ EXACTITUD Y PRECISIÓN PARA LOS ANALITOS ENUMERADOS EN ESTE PROSPECTO._x000D_

English

RANDOX EVIDENCE MULTISTAT ARDS CONTROLS ARE DESIGNED TO BE USED AS AN ANALYZED QUALITY CONTROL IN ROUTINE MONITORING DE_x000D_ ACCURACY AND PRECISION FOR THE ANALYTES LISTED IN THIS PROSPECTO._x000D_

About this record

Access comprehensive regulatory information for 2. ARDS INTERNAL QC CONTROL MARCA: RANDOX (2. ARDS INTERNAL QC CONTROL MARCA: RANDOX) in the Colombia medical device market through Pure Global AI's free database. This I medical device is registered under INVIMA analysis ID b102273862413112a5d41305d1544e82 and manufactured by BIOLORE LTDA. The device was registered on February 22, 2034.

This page provides complete registration details including product type (REACTIVOS IN VITRO), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.